I now have enough information to give a comprehensive answer. Here is a thorough summary:
Life Expectancy of an HIV-Positive Person
The Short Answer
With modern antiretroviral therapy (ART), a person diagnosed with HIV today — if treated early and consistently — can expect to live as long as someone without HIV, reaching a near-normal lifespan well into their 70s or 80s.
With Treatment (ART)
This is the most important factor. ART has transformed HIV from a fatal disease into a manageable chronic condition.
| Scenario | Life Expectancy |
|---|
| Diagnosed early, starts ART promptly, good adherence | Approaching that of the general population |
| 20-year-old starting ART today (high-income country) | Expected to live into their mid-to-late 70s |
| Delayed diagnosis or late ART start | Reduced, but still greatly improved vs. no treatment |
| Untreated HIV progressing to AIDS | Average survival after AIDS diagnosis: ~2–3 years without treatment |
Key findings from current evidence:
- People on suppressive ART with virologic control (undetectable viral load) now have a life expectancy approaching the general population — confirmed in both developed and developing countries.
- A landmark Kaiser Permanente study found life expectancy for HIV+ people on ART increased dramatically from 1996 onward.
- A 2024 study from Spain confirmed that people with HIV on ART have life expectancy comparable to HIV-negative peers.
"HIV-infected individuals who take antiretroviral therapy with virologic control now have a life expectancy that is approaching the life expectancy of the general population."
— Goldman-Cecil Medicine, 26th Ed.
Without Treatment (Natural History)
Without ART, HIV follows a predictable progression:
- Acute HIV infection (2–4 weeks after exposure): Flu-like illness, very high viral load
- Chronic/Latent phase (average 8–10 years): Few or no symptoms; CD4 count slowly declines
- AIDS (CD4 < 200 cells/mm³ or AIDS-defining illness): Without treatment, survival is typically ~1–3 years
So untreated HIV from infection to death averages roughly 10–12 years total, though this varies widely.
Factors That Affect Life Expectancy
| Factor | Impact |
|---|
| Age at diagnosis | Younger = more years gained with treatment |
| CD4 count at ART start | Higher CD4 = better outcomes |
| ART adherence | Critical — missed doses allow viral rebound |
| Viral load suppression | Undetectable viral load = near-normal prognosis |
| Co-infections | Hepatitis B/C, TB worsen outcomes |
| Comorbidities | HIV-positive people develop cardiovascular disease, cancers, and metabolic problems ~16 years earlier than HIV-negative peers |
| Access to healthcare | Major determinant in low-income settings |
| Substance use, smoking | Shorten life expectancy significantly |
An Important Nuance: Quality of Life
Even when total lifespan is similar, HIV-positive people on ART spend more years living with significant comorbidities — including cardiovascular disease, renal disease, osteoporosis, and neurocognitive issues — on average 16 years earlier than HIV-negative individuals. This is an active area of research and clinical management.
Key Takeaway
| Status | Life Expectancy |
|---|
| HIV+ on early, consistent ART | Near-normal (≈ general population) |
| HIV+ with delayed treatment | Moderately reduced |
| HIV+ untreated → AIDS | ~10–12 years from infection |
The most important step after an HIV-positive diagnosis is starting ART immediately — current guidelines recommend same-day or next-day initiation regardless of CD4 count.
Sources: Goldman-Cecil Medicine (26th Ed.); Cummings Otolaryngology; Epidemiology and prognosis of HIV 2024 – PubMed 38383266